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The inaugural issue of Synthetic and Systems Biotechnology co-
incides with the celebration of the 2015 Nobel Prize in Physiology
or Medicine, which was awarded to Profs. Youyou Tu, William C.
Campbell and Satoshi O¯mura for the discovery of artemisinin and
avermectin, respectively. The eﬃcacy of both artemisinin and
avermectin as parasitic disease treatments won the recognition of
the whole world, revealing the dawning of renaissance of natural
product-based drug discovery. Although artemisinin was original-
ly innovated by the Chinese, the reality is that China has neither
proprietary intellectual property rights nor unique leading tech-
nology or international market shares. The situation of avermectin
is totally opposite. China is the only avermectin producing country
in the world with an annual sale above 3 billion RMB, kudos greatly
to the power of Synthetic and Systems Biotechnology (reviewed in
this issue).
Synthetic and Systems Biotechnology is reshaping the way humans
live, but there are only a few journals dedicated to this ﬁeld. I want
to take this opportunity to brieﬂy introduce you to our journal that
addresses the need for a new outlet for high quality peer re-
viewed papers reporting research into the nature, extent and impacts
of the presence of Synthetic and Systems Biotechnology. I recall some
debate with my associate editors, Professors Eriko Takano from
Manchester Univ. (UK), Jason Sello from Brown Univ. (USA) and Dan
Luofrom Cornel Univ. (USA), about how we would deﬁne “Synthet-
ic and Systems Biotechnology.”We settled on the following: Synthetic
and Systems Biotechnology aims to promote the communication of
original research in synthetic and systems biology, with strong em-
phasis on applications toward biotechnology. The journal publishes
high-quality research; focusing on integrative approaches to enable
the understanding and design of biological systems, and research
to develop the application of systems and synthetic biology to natural
systems. This journal publishes articles, short notes, methods, mini
reviews, and conference reviews, including new technologies, pro-
cesses, methods, materials, systems, and applications. In this
inaugural issue, we had one short note, three mini reviews and four
full research articles.
I hope I’ve illustrated the need for Synthetic and Systems Bio-
technology as well as its value as a true home for research in this
area, but I appreciate that this is not always all that is on authors’
minds. For this reason, I am excited to be able to highlight the
ongoing support provided to the journal and its authors by our pub-
lisher, KeAi Publishing. Despite its reasonably short history, KeAi’s
associationwith its two founding partners, Elsevier and China Science
Publishing & Media, as well as their commitment to Science will
allow the journal’s authors to enjoy a wide range of beneﬁts. These
include free of charge open access publication for the ﬁrst year,
cutting edge publishing systems and fervent dedication to promo-
tion and the widest dissemination possible.
No journal editor ever stands alone and so we are very happy
to be able to introduce some of the other people who helped and
drove the journal forward, including our editorial board members
in the ﬁeld. Our thanks also go to Dr. Keith De Blanger and his out-
going team of publishers including Ms. Hua Bai and Dr. Emilie Wang
for their skilled stewardship of the journal so far.
In conclusion, I wish you happy reading of this ﬁrst issue, and
look forward to the next, and hope that you will want to be part
of shaping and developing the Journal in the future with your own
discoveries. Enjoy!
Lixin Zhang
Professor, Editor-in-Chief, Synthetic and Systems Biotechnology
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